Pulse Biosciences, Inc.
PLSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $700 | $1,418 |
| % Growth | – | -100% | -50.6% | – |
| Cost of Goods Sold | $0 | $1,207 | $11,944 | $1,968 |
| Gross Profit | $0 | -$1,207 | -$11,244 | -$550 |
| % Margin | – | – | -1,606.3% | -38.8% |
| R&D Expenses | $32,336 | $27,797 | $20,839 | $28,640 |
| G&A Expenses | $23,921 | $15,777 | $13,955 | $19,073 |
| SG&A Expenses | $23,921 | $15,777 | $25,974 | $33,824 |
| Sales & Mktg Exp. | $0 | $0 | $12,019 | $14,751 |
| Other Operating Expenses | $0 | -$1,207 | $0 | $0 |
| Operating Expenses | $56,257 | $42,367 | $46,813 | $62,464 |
| Operating Income | -$56,257 | -$43,574 | -$58,057 | -$63,014 |
| % Margin | – | – | -8,293.9% | -4,443.9% |
| Other Income/Exp. Net | $2,672 | $1,364 | -$448 | -$646 |
| Pre-Tax Income | -$53,585 | -$42,210 | -$58,505 | -$63,660 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$53,585 | -$42,210 | -$58,505 | -$63,660 |
| % Margin | – | – | -8,357.9% | -4,489.4% |
| EPS | -0.92 | -0.88 | -1.72 | -2.28 |
| % Growth | -4.5% | 48.8% | 24.6% | – |
| EPS Diluted | -0.92 | -0.88 | -1.72 | -2.28 |
| Weighted Avg Shares Out | 58,398 | 48,038 | 33,935 | 27,964 |
| Weighted Avg Shares Out Dil | 58,398 | 48,038 | 33,935 | 27,964 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,672 | $2,464 | $0 | $0 |
| Interest Expense | $0 | $1,100 | $0 | $0 |
| Depreciation & Amortization | $1,178 | $1,207 | $1,355 | $1,146 |
| EBITDA | -$55,079 | -$42,367 | -$56,702 | -$61,868 |
| % Margin | – | – | -8,100.3% | -4,363% |